ZymoGenetics Punches Bristol-Myers With Suit

Law360, New York (August 15, 2006, 12:00 AM EDT) -- Drug developer ZymoGenetics Inc. has hit Bristol-Myers Squibb Co. with a lawsuit, accusing the pharmaceutical giant of infringing on its patented fusion protein technology.

On Monday, the company revealed that it had filed suit in the U.S. District Court for the District of Delaware, alleging that Bristol-Myers had violated its intellectual property.

"We have a number of patents on fusion protein technology, which we believe are being infringed by Bristol-Myers Squibb," said Bruce L.A. Carter, the president and chief executive officer of ZymoGenetics. "It is important...
To view the full article, register now.